Current uses of gadolinium chelates for clinical magnetic resonance imaging examination of the liver

Applied Radiology

Volumn , Issue SUPPL., 2001, Pages 137-152

  Low, R N ^a  

^a San Diego Imaging Medical Group   (United States)

Author keywords

Gadolinium; Liver; Liver neoplasms; Magnetic resonance

Indexed keywords

FAT; GADODIAMIDE; GADOLINIUM CHELATE; GADOLINIUM PENTETATE MEGLUMINE; GADOTERIDOL;

ARTICLE; AUTOSOMAL DOMINANT DISORDER; BILE DUCT CARCINOMA; BUDD CHIARI SYNDROME; CANCER STAGING; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DRUG ACCUMULATION; GASTROINTESTINAL TUMOR; HAMARTOMA; HUMAN; KIDNEY; KIDNEY POLYCYSTIC DISEASE; LIPID STORAGE; LIVER ABSCESS; LIVER ADENOMA; LIVER CELL CARCINOMA; LIVER CYST; LIVER EXAMINATION; LIVER HEMANGIOMA; LIVER METASTASIS; LIVER PERFUSION; LIVER TUMOR; LYMPHADENOPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; OMENTUM; PANCREAS; PERITONEUM TUMOR; PORTAL VEIN THROMBOSIS; PORTOSYSTEMIC ANASTOMOSIS; SPLEEN; TUMOR VOLUME;

EID: 0034940780     PISSN: 01609963     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Biodistribution and toxicity of MR imaging contrast agent media
2. Proton relaxation enhancement
3. Currently available gadolinium chelates
4. Liver: MRI of the abdomen and pelvis: A Text-Atlas
5. Focal liver disease: Comparison of dynamic contrast-enhanced CT and T2-weighted fat suppressed, FLASH and dynamic gadolinium-enhanced MR imaging at 1.5 T
6. Differential diagnosis of focal liver lesions: Role of spin-echo and contrast-enhanced dynamic MR imaging
7. Dynamic breath-hold multiplanar spoiled gradient-recalled MR imaging with gadolinium enhancement for differentiating hepatic hemangiomas from malignancies at 1.5 T
8. Transient increased segmental hepatic enhancement distal to portal vein obstruction on dynamic gadolinium-enhance gradient echo MR images
9. Ultrasound and MR findings in acute Budd-Chiari syndrome with histopathologic correlation
10. MR imaging of peritoneal disease: Comparison of contrast-enhanced fast multiplanar spoiled gradient-recalled and spin-echo MR imaging
11. Ovarian cancer: Comparison of findings with per-fluorocarbon-enhanced MR imaging. In-111-CYT-103 immunoscintigraphy, and CT
12. Peritoneal tumor: MR imaging with dilute oral barium and intravenous gadolinium-containing contrast agents compared with unenhanced MR imaging and CT
13. Comparison of magnetic resonance imaging and endoscopy in distinguishing the type and severity of inflammatory bowel disease
14. MR imaging of the gastrointestinal tract with IV gadolinium and diluted barium oral contrast media compared with unenhanced MR imaging and CT
15. Bowel disease: Prospective comparison of CT and 1.5-T pre- and postcontrast MR imaging with T1-weighted fat-suppressed and breath-hold FLASH sequences
16. Contrast agents for MR imaging of the liver
17. MR diagnosis of hepatic metastases from neuroendocrine tumors versus hemangiomas: Relative merits of dynamic gadolinium chelate-enhanced gradient-recalled echo and unenhanced spin-echo images
18. Hypervascular malignant liver lesions: Comparison of various MR imaging pulse sequences and dynamic CT
19. Hepatic metastases and cavernous hemangiomas: Distinction with standard-and triple-dose gadoteridol-enhanced MR imaging
20. Spin-echo and dynamic gadolinium-enhanced FLASH MR imaging of hepatocellular carcinoma: Correlation with histopathologic findings
21. Evaluation of malignant biliary obstruction: Efficacy of fast multiplanar spoiled gradient-recalled MR imaging vs spin-echo MR, CT, and cholangiography
22. Contrast-enhanced MR imaging of intrahepatic cholangiocarcinoma: Pathologic correlation study
23. Peribiliary cysts in liver cirrhosis: US, CT, and MR findings
24. The radiologic and pathologic spectrum of biliary hamartomas
25. Hepatic hemangiomas: A multi-institutional study of appearance on T2-weighted and serial gadolinium-enhanced gradient-echo MR images
26. Differentiation of hepatic hemangiomas from metastases by dynamic contrast-enhanced MR imaging
27. Small hepatocellular carcinoma and cavernous hemangioma: Differentiation with dynamic FLASH MR imaging with Gd-DTPA
28. Differentiation between multiple liver hemangiomas and liver metastases of gastrinomas: Value of enhanced MRI
29. Hypervascular liver lesions: Differentiation of focal nodular hyperplasia from malignant tumors with dynamic gadolinium-enhanced MR imaging
30. Focal nodular hyperplasia of the liver: Assessment with contrast-enhanced TurboFLASH MR imaging
31. Focal nodular hyperplasia of the liver: Assessment of hemodynamic and angioarchitectural patterns with gadolinium chelate-enhanced 3D spoiled gradient-recalled MRI and maximum intensity projection reformatted images
32. Focal nodular hyperplasia of the liver: MR imaging and pathologic correlation in 37 patients
33. Hepatic adenoma: MR findings in 51 pathologically proved lesions
34. Hepatic adenoma: MR characteristics and correlation with pathologic findings
35. Hepatocellular adenoma: MR imaging features with pathologic correlation
36. Hepatic abscesses: MR imaging findings
37. Focal manifestations of diffuse liver disease at MR imaging
38. Solitary hepatic metastasis: Comparison of dynamic contrast-enhanced CT and MR imaging with fat-suppressed T2-weighted, breath-hold T1-weighted FLASH, and dynamic gadolinium-enhanced FLASH sequences
39. Focal liver lesions: Characterization with nonenhanced and dynamic contrast material-enhanced MR imaging
40. Liver metastases: Improved detection with dynamic gadolinium-enhanced MR imaging
41. Liver lesion detection, characterization, and effect on patient management: Comparison of single-phase spiral CT and current MR techniques
42. Peripheral washout: A sign of malignancy on dynamic gadolinium-enhanced MR images of focal liver lesions
43. Dysplastic nodules and hepatocellular carcinoma: Thin-section MR imaging of explanted cirrhotic livers with pathologic correlation
44. Hepatocellular carcinoma: Correlation of MR imaging and histopathologic findings
45. Small hepatocellular carcinoma in patients with chronic liver damage. Prospective comparison of detection with dynamic MR imaging and helical CT of the whole liver
46. Small hepatocellular carcinoma and cavernous hemangioma: Differentiation with dynamic FLASH MR imaging with Gd-DTPA
47. Dynamic contrast-enhanced MR imaging of fibrolamellar hepatocellular carcinoma
48. Bile duct disease: Prospective comparison of ERCP, CT and fat-suppressed MRI
49. Imaging of intrahepatic cholangiocarcinoma: 2. Hilar cholangiocarcinoma
50. Imaging of intrahepatic cholangiocarcinoma: 1. Peripheral cholangiocarcinoma
51. Intrahepatic cholangiocarcinoma: Spin-echo and contrast-enhanced dynamic MR imaging
52. Treatment of hepatocellular carcinoma with percutaneous ethanol injection: Evaluation with contrast-enhanced MR imaging
53. Enhanced MR imaging of the liver after ethanol treatment of hepatocellular carcinoma: Evaluation of areas of hyperperfusion adjacent to the tumor
54. CT of the liver in patients with metastatic breast carcinoma treated by chemotherapy: Findings simulating cirrhosis
55. Diagnosis of Budd-Chiari syndrome: Comparison between sonography and MR angiography
56. Hepatic infarction caused by arterial insufficiency: Spectrum and evolution of CT findings
57. Straight border sign of the liver. Spectrum of CT appearances and causes
58. Portal vein thrombosis: Imaging findings
59. CT of portal venous occlusion
60. Benign and malignant portal vein thrombosis: Differentiation by CT characteristics
61. Primary ovarian cancer: Prospective comparison of contrast-enhanced CT and pre- and postcontrast, fat-suppressed MR imaging with histologic correlation
62. Small bowel neoplastic disease: Demonstration by MRI
63. Crohn's disease: Pilot study comparing MRI of the abdomen with clinical evaluation